Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

879 results

Ingmar de Groot

Partner Amsterdam

Joost van 't Hof

Junior Associate Amsterdam

Carl Wettinck

Senior Associate Brussels

Repsol: Dutch parent company cannot simply be used as anchor defendant to create jurisdiction

Foreign entities are often sued in the Netherlands on the basis of the ‘anchor defendant’ construction.

Repsol: Nederlandse moedervennootschap kan niet zomaar als ankergedaagde worden gebruikt om rechtsmacht te creëren

Buitenlandse partijen worden vaak in Nederland gedagvaard via de "ankergedaagde"-constructie.

No reduction order for Shell on appeal: what does this mean?

Shell climate case on appeal: no CO2 reduction order. What does this mean for the future? And for other companies?

Geen reductiebevel voor Shell in hoger beroep: wat betekent dit?

Hoger beroep Shell-klimaatzaak: geen CO2-reductiebevel. Wat betekent dit voor de toekomst? En voor andere bedrijven?

The era of FDI screenings kicks off in Belgium

The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.

Stibbe advises Strohm

Stibbe advised Strohm Holding on another EUR 15 million joint investment.

Abuse of economic dependence does not require contractual relationship

On 20 February 2025, the Belgian Supreme Court confirmed that under Belgian law an abuse of economic dependence may be found even in a situation where there is no contractual relationship between the companies involved.

C'est le ton qui fait la musique – The end of employer copyrights?

The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here.

The long and (un)winding road of ‘killer acquisition’ Illumina/Grail

Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.

If you have nothing nice to say…Teva fined heavily for abusive conduct

Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.

The ECJ’s ruling in Servier: Never Settle For Less

Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.

Commission steers market definition to the 21st century

Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.

Pagination

  • Previous page
  • Page 46
  • Page 47
  • Page 48
  • Current page 49
Reset filters
Date
Content type
  • Article (512)
  • Event (17)
  • Inside Stibbe (28)
  • Interview (1)
  • Matter (206)
  • Podcast (6)
  • People (109)
Expertise
  • (-) EU and Competition Law (486)
  • (-) Litigation and Arbitration (435)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (437)
  • Capital Markets (251)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (884)
  • Corporate Investigations (32)
  • Criminal Law and Enforcement (148)
  • Employment, Benefits and Pensions (419)
  • Energy, Industry and Climate (320)
  • Environment and Planning (913)
  • ESG & Sustainability (307)
  • Financial Regulation (176)
  • Healthcare and Life Sciences (85)
  • Infrastructure and Mobility (205)
  • Insurance (36)
  • Intellectual Property (120)
  • Investment Funds (147)
  • Mass Litigation (92)
  • Privacy and Data Protection (206)
  • Private Equity (200)
  • Procurement Law (128)
  • Public Law (1219)
  • Real Estate (487)
  • Restructuring and Insolvency (116)
  • Sports (27)
  • Tax (454)
  • Tech (197)
  • Technology, Media and Telecommunications (339)
  • Unfair Competition and Consumer Protection (200)
Jurisdiction
  • BE Law (117)
  • EU Law (317)
  • LU Law (16)
  • NL Law (573)
Language
  • Dutch (124)
  • English (748)
  • French (7)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Important Information